Key Insights

Highlights

Treatment Research

1 treatments under study, led by Sentinel Lymph Node Biopsy

Related Conditions

Often studied with 8 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 2 (1)

Trial Status

Recruiting1
Unknown1

Clinical Trials (2)

Showing 2 of 2 trials
NCT05797415Recruiting

Sentinel Lymph Node Biopsy in Ocular Surface and Adnexal Cancers

NCT05013099Phase 2Unknown

Study of Zirconium Zr 89 Crefmirlimab Berdoxam PET/CT in Subjects With Advanced or Metastatic Malignancies

Showing all 2 trials

Research Network

Common Treatments

  • Sentinel Lymph Node Biopsy1

Active Sponsors

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
  • ImaginAb, Inc.1

Top Investigators

Related Conditions

  • Ocular Basal Cell Carcinoma1
  • Non Small Cell Lung Cancer1
  • Conjunctival Melanoma1
  • Ocular Sebaceous Carcinoma1
  • Renal Cell Carcinoma1

Activity Timeline